194 related articles for article (PubMed ID: 28162277)
1. STAT3 Regulation By S-Nitrosylation: Implication In Cancer.
Singh I; Kim J; Singh AK; Sharma AK; Won JS
Redox Biol; 2015 Aug; 5():416-417. PubMed ID: 28162277
[TBL] [Abstract][Full Text] [Related]
2. STAT3 regulation by S-nitrosylation: implication for inflammatory disease.
Kim J; Won JS; Singh AK; Sharma AK; Singh I
Antioxid Redox Signal; 2014 Jun; 20(16):2514-27. PubMed ID: 24063605
[TBL] [Abstract][Full Text] [Related]
3. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
[TBL] [Abstract][Full Text] [Related]
4. The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.
Yang X; He G; Hao Y; Chen C; Li M; Wang Y; Zhang G; Yu Z
J Neuroinflammation; 2010 Sep; 7():54. PubMed ID: 20828402
[TBL] [Abstract][Full Text] [Related]
5. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
6. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
7. Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways.
Yu Q; Zeng K; Ma X; Song F; Jiang Y; Tu P; Wang X
Int Immunopharmacol; 2016 Sep; 38():104-14. PubMed ID: 27261558
[TBL] [Abstract][Full Text] [Related]
8. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
9. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
10. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
Chakravarti N; Myers JN; Aggarwal BB
Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
[TBL] [Abstract][Full Text] [Related]
11. Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia.
Weng L; Zhang H; Li X; Zhan H; Chen F; Han L; Xu Y; Cao X
Int Immunopharmacol; 2017 Mar; 44():1-8. PubMed ID: 27998743
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
[TBL] [Abstract][Full Text] [Related]
13. Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
Giri S; Rattan R; Deshpande M; Maguire JL; Johnson Z; Graham RP; Shridhar V
PLoS One; 2014; 9(6):e97897. PubMed ID: 24887420
[TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages.
Kang YS; Kang YG; Park HJ; Wee HJ; Jang HO; Bae MK; Bae SK
J Pineal Res; 2013 Oct; 55(3):294-303. PubMed ID: 23869429
[TBL] [Abstract][Full Text] [Related]
15. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
16. A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of STAT3 and negative regulation of JAK2-STAT3 pathway.
Cao F; Li M; Wang W; Yi Y; Chen Y; Liu H
Biochem Pharmacol; 2024 Apr; 222():116068. PubMed ID: 38387529
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
18. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
20. Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide.
Li WY; Li FM; Zhou YF; Wen ZM; Ma J; Ya K; Qian ZM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]